Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, expanding PAD-related comorbidities, and rising adoption of premium-priced drug-eluting products. Rising procedure volumes for iliac and lower limb indications and the increasing adoption of endovascular techniques over surgical intervention will also fuel market growth, particularly in China. However, cost constraints in publicly funded healthcare systems and limited reimbursement in the region continue to hinder the adoption of premium-priced devices and limit the pace of revenue expansion.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in the Asia Pacific region from 2019 through 2033.

Table of contents


Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Neurostimulation Devices – Market Insights – United States
The US neurostimulation device market will be driven by strategic acquisitions, rapid adoption of novel technologies and increasing availability of advanced products, and new approvals and device…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…